ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Surveys"

  • Abstract Number: 0600 • ACR Convergence 2025

    Toward a Consensus-Based Definition of Difficult-to-Treat Systemic Lupus Erythematosus: A Multinational Survey of Clinicians from the MENA Region

    Ahlam Almarzooqi1, Sarah Al Qassimi2, Nelly Ziade3, Mohammed Omair4, Samar Al emadi5, FARIDA ALBALUSHI6, Waleed Hafiz7, Hiba Khogali8, Saadeya Naji9, Suzan Attar10, Khalid Alnaqbi11 and Rajaie Namas12, 1Emirates Health Services, Sharjah, United Arab Emirates, 2Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, 3Department of Rheumatology, Saint-Joseph University and Hotel-Dieu de France, Beirut, Lebanon, 4King Saud university, Riyadh, Saudi Arabia, 5Hamad medical corporation, Doha, Qatar, 6Royal hospital, Dubia, United Arab Emirates, 7Umm Al-Qura university, Makkah, Makkah, Saudi Arabia, 8Madinat Zayed Hospital , Al Dhafra hospitals, Abu Dhabi, Abu Dhabi, United Arab Emirates, 9Salmaniya medical complex, BAHRAIN, Al Asimah, Bahrain, 10King Abdulaziz University, Saudi Arabia, Jeddah, Saudi Arabia, 11Sheikh Tahnoon Medical city, Al Ain, United Arab Emirates, 12Cleveland Clinic Abu Dhabi, Detroit, MI

    Background/Purpose: Difficult-to-treat systemic lupus erythematosus (D2T-SLE) presents a major challenge due to disease heterogeneity and a lack of unified classification. While the D2T concept has…
  • Abstract Number: 2537 • ACR Convergence 2025

    Variation in Treatment Approaches in IgA-Vasculitis Among Pediatricians and Pediatric rheumatologists: A Cross-Sectional International Survey

    Merav Heshin Bekenstein1, Tali Elbaz2, Yael Illous2 and Barak Kandell3, 1Tel Aviv Medical Center Israel, Binyamina, Tel Aviv, Israel, 2School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv, Israel, 3The Academic College of Tel Aviv-Yafo, Tel Aviv, Israel

    Background/Purpose: IgA Vasculitis (IgAV) is the most common small-vessel vasculitis in children. Although there is no evidence-based recommendations for treating IgAV, the European SHARE recommendations…
  • Abstract Number: 1923 • ACR Convergence 2025

    A Real-World Survey On Physicians’ Perspectives Of Uncontrolled Gout And Gout Management Practices.

    John Botson1, Menaka Bhor2, Nathan Meyer2, Molly Edwards3, Emily Goddard3, Victoria Barton4 and Jeff Peterson5, 1Orthopedic Physicians of Alaska, Anchorage, AK, 2Sobi Inc, Waltham, MA, 3Adelphi Real World, Bollington, United Kingdom, 4Adelphi Real World, Macclesfield, United Kingdom, 5Western Washington Arthritis Clinic, Bothell, WA

    Background/Purpose: Managing uncontrolled gout (UG) can involve a multi-disciplinary approach involving physicians of different specialities, all of whom may have differing perspectives or approaches for…
  • Abstract Number: 0738 • ACR Convergence 2025

    Real World Steroid Burden, Treatment Patterns, and Rheumatologists’ Perceptions on Advanced Therapy in Giant Cell Arteritis

    Anisha Dua1, Aditi Kadakia2, Patrick Zueger3, Simran Marwaha4, Nathaniel Zerad3, Arathi Setty3, William Jones4 and Valerie Devauchelle5, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2AbbVie Inc, Woburn, MA, 3AbbVie Inc, North Chicago, IL, 4Adelphi Real World, Bollington, United Kingdom, 5UBO, Brest, France

    Background/Purpose: Giant cell arteritis (GCA) is the most common vasculitis in patients 50 years and older. Glucocorticoids (GC) are the mainstay of treatment for GCA…
  • Abstract Number: 2318 • ACR Convergence 2025

    Practice Patterns and Barriers in the Referral, Management and Monitoring of Axial Spondyloarthritis: Insights from an Online Survey of Rheumatologists

    Khalid Alnaqbi1, Mohammed Alaswad2, Tariq Al Araimi3, Amr Mahmoud4, Samar Al emadi5, Hanan Al Rayyes6, Khuloud Mohammed7 and Xenofon Barliakos8, 1Sheikh Tahnoon Medical city, Al Ain, United Arab Emirates, 2Faculty of Human Medicine, University of Hama, Hama, Syria, 3Royal Hospital, Muscat, Oman, 4Department of Pharmacology, Pharmacy Program, Oman College of Health Sciences, Muscat, Oman, 5Hamad medical corporation, Doha, Qatar, 6Department of Medicine, Prince Sultan Military Medical City, Riyad, Saudi Arabia, 7Farwaniya Hospital, Kuwait, Kuwait, 8Ruhr-University Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: There is a dearth of literature exploring challenges faced by rheumatologists in the referral, diagnosis, management, and monitoring of patients with suspected axial spondyloarthritis…
  • Abstract Number: 1915 • ACR Convergence 2025

    Innovative Clinical Trial Recruitment Approaches in Lupus Research: LuCIN Site Perspectives on Use of Social Media and Artificial Intelligence

    Brandon Jackson1, Roberto Caricchio2, Saira Sheikh3, Meenakshi Jolly4, Jennifer Meriwether5, Taylor Irons6, Taylor Adjei7, Caroline Donovan8, Carla Menezes7, Courtney Canton9, Aimee Williams10, Maya Merrell9 and Stacie Bell11, 1Lupus Therapeutics, Miami, FL, 2University of Massachusetts Chan Medical School, Worcester, MA, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Rush University, Chicago, IL, 5Lupus Therapeutics, Westminster, CO, 6Lupus Therapeutics, Houston, TX, 7Lupus Therapeutics, New York, NY, 8Lupus Therapeutics, Charlottesville, VA, 9Lupus Therapeutics, Charleston, SC, 10Lupus Therapeutics, Raleigh, NC, 11Lupus Therapeutics, Lakewood, CO

    Background/Purpose: Lupus disproportionately impacts racial and ethnic minorities, yet these groups remain underrepresented in clinical trials. Lupus Therapeutics, overseeing the Lupus Clinical Investigators Network (LuCIN),…
  • Abstract Number: 0375 • ACR Convergence 2025

    Association of Glucocorticoid Toxicity Index Scores with Quality-of-Life and Healthcare Resource Utilization at 6 Months in a Real-World Cohort of Individuals Receiving Glucocorticoids

    Naomi Patel1, Jiaqi Wang1, Isha Jha2, Grace McMahon1, Tania Chiha3, Hyon K. Choi4 and John Stone5, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, 3Mount Auburn Hospital, Boston, 4MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 5Massachusetts General Hospital , Harvard Medical School, Concord, MA

    Background/Purpose: Glucocorticoids (GCs) are used long-term by approximately 1% of the adult population and contribute to excess morbidity and mortality. We prospectively assessed Glucocorticoid Toxicity…
  • Abstract Number: 2216 • ACR Convergence 2025

    Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors

    Krista Topalsky1, Chelsea Guan2, Lindsay Frumker3, Dana Nachawati2, Areeb Tiwana4, Meghan Gump2, Omer Pamuk5 and Marina Magrey6, 1University Hospitals, Shaker Heights, OH, 2University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, 3University hospitals Cleveland medical center, Highland Heights, OH, 4Canton Medical Education Foundation, Canton, OH, 5University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 6Case Western Reserve University School of Medicine/University Hospitals Cleveland, Richfield, OH

    Background/Purpose: Building on our 2024 ACR study (Topalsky et al.) that described broad knowledge gaps and interest in reproductive health education among women with rheumatic…
  • Abstract Number: 1419 • ACR Convergence 2025

    Effectivenss of an educational program on non-radiographic axial spondyloarthritis

    Hideto Kameda1, Toshihide Shuto2, Akimichi Morita3, Yasuharu Nakashima4, Kiyoshi Matsui5, Masaaki Mori6 and Masahiro Yamamura7, 1Department of Internal Medicine, Toho University, Tokyo, Japan, 2Chiyoda Hospital, Hyuga, Japan, 3Department of Geriatric and Environmental Dermatology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan, 4Kyushu University, Fukuoka, Japan, 5Amagasaki Chuo Hospital, Amagasaki, Japan, 6Institute of Science Tokyo, Tokyo, Japan, 7Okayama Saiseikai General Hospital, Okayama, Japan

    Background/Purpose: Non-radiographic axial spondyloarthritis (nr-axSpA) is a relatively new disease concept. We developed an educational program to promote early and appropriate referral to specialists based…
  • Abstract Number: 0374 • ACR Convergence 2025

    Assessing Attitudes and Barriers to Vaccination in Pediatric Rheumatic

    Merav Heshin Bekenstein1, Rebecca Hetrick2, Vidya Sivaraman3, Beth Rutstein4, Albert Chow5, Peter Chiraseveenuprapund6, Vincent Del Gaizo7, Melanie Kohlheim8, guy Brock9, Sapuni Chandrasena9, Chloé Janse van Rensburg10 and Marina Gad El Sayed11, 1Tel Aviv Medical Center Israel, Binyamina, Tel Aviv, Israel, 2Indiana University School of Medicine, Indianapolis, IN, 3Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 4The Children's Hospital of Philadelphia, Wynnewood, PA, 5Loma Linda University, Loma Linda, CA, 6University of Utah, Salt Lake City, UT, 7Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, NJ, 8CARRA, Granville, OH, 9The Ohio State University Wexner Medical Center, Columbus, OH, 10Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada, 11University of California, Riverside School of Medicine, Riverside, CA

    Background/Purpose: Vaccine-preventable diseases pose greater risk to children with rheumatic diseases treated with immunosuppressive therapies and to those with underlying immune dysregulation. Despite the importance…
  • Abstract Number: 2201 • ACR Convergence 2025

    Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician Surveys

    Akhil Sood1, Leanna Wise2, Sadaf Sediqi1, Alyssa Howren1, Amanda Moyer1, Ellie Diamond1, Yashaar Chaichian3 and Julia F Simard4, 1Stanford University, Palo Alto, CA, 2LAGMC/Keck Medicine of USC, Los Angeles, 3Stanford University, Stanford, CA, 4Stanford Medicine, Stanford, CA

    Background/Purpose: The American College of Rheumatology has established guidelines for managing reproductive health in patients with rheumatic diseases. We assessed contraception use and counseling of…
  • Abstract Number: 1265 • ACR Convergence 2025

    Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations

    Emily Gutowski1, Joshua Novack2, Allyson Covello2, Philip Carlucci3, Scott Goldberg1, Mary Guan4, Marcus Hines2, Elliot Philips2, Michael Pillinger5 and Sara Stream6, 1New York University Grossman School of Medicine, Brooklyn, NY, 2New York University Grossman School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4NYU Grossman SOM, Brooklyn, NY, 5New York University Grossman School of Medicine, New York,, NY, 6New York University Grossman School of Medicine, Great Neck, NY

    Background/Purpose: Patients with rheumatic diseases face complex and chronic diagnoses that require close monitoring and frequent communication with their providers. Given increasing challenges to in-person…
  • Abstract Number: 0367 • ACR Convergence 2025

    Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus

    Hannah Concannon1, Kai Sun2, Jennifer Rogers3, Megan Clowse4, Rachel Randell2, Mithu Maheswaranathan5, Lisa Criscione-Schreiber5, Nathaniel Harris6, Amanda Eudy7 and Rebecca Sadun2, 1Duke University School of Medicine, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke, Durham, NC, 4Duke University, Chapel Hill, NC, 5Duke University School of Medicine, Durham, NC, 6Duke University Medical Center, Durham, NC, 7Duke University, Raleigh, NC

    Background/Purpose: Medication adherence poses a challenge for patients with SLE, especially younger patients, who often experience both more active disease and more intensive treatments than…
  • Abstract Number: 0164 • ACR Convergence 2024

    Sleep Quality Is Associated with Perceived Memory Performance in Females with Osteoarthritis: A Population-based Cross-sectional Study

    Linda Li1, Hui Xie2, Leo Lu3, Helen Prlic3, Diane Lacaille4, J. Antonio Avina-Zubieta4, Jolanda Cibere5 and John Esdaile3, and PRECISION Team, 1Arthritis Research Canada & University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Simon Fraser University, Vancouver, BC, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 5University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Osteoarthritis (OA) is associated with increased risks of cognitive impairment. Cognitive health is affected by an interplay of lifestyle, metabolic, and biological factors; however,…
  • Abstract Number: 1252 • ACR Convergence 2024

    Rheuminating About Drugs, Sex, and Alcohol? Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease

    Matthew Sholdice1, Meghan Pancucci2, gauri gupta3, Simran Heera4, KAREN BEATTIE5 and Michelle Batthish6, 1McMaster University, London, ON, Canada, 2McMaster University, Hamilton, Canada, 3McMaster Univeresity, Hamilton, Canada, 4McMaster University, Mississauga, ON, Canada, 5McMaster University, Hamilton, ON, Canada, 6McMaster Children's Hospital, Hamilton, ON, Canada

    Background/Purpose: Adolescents and young adults (AYA) with chronic rheumatic disease (RD) often engage in behaviours, such as alcohol consumption, recreational drug use, and sexual activity,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology